Skip to content
healthcare.dev

Aspi-Cor

NDC 50844-675, Aspirin, tablet, delayed release, from L.N.K. International, Inc..

Product NDC
50844-675
Status
Listed
Labeler
L.N.K. International, Inc.
Dosage form
TABLET, DELAYED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M013
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50844-675 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ASPIRIN81 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; Decreased Prostaglandin Production [PE]; Nonsteroidal Anti-inflammatory Drug [EPC]; Platelet Aggregation Inhibitor [EPC]

Package NDCNDC-11Package
50844-675-035084406750310 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (50844-675-03)
50844-675-26508440675261 BAG in 1 BOX (50844-675-26) / 85000 TABLET, DELAYED RELEASE in 1 BAG
50844-675-3250844067532120 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (50844-675-32)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 50844-675 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50844-675 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50844-675. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.